New stent graft could save lives from deadly aortic tear
NCT ID NCT06827990
First seen Oct 31, 2025 · Last updated Jun 19, 2026 · Updated 32 times
Summary
This study tests a new device called the GORE ascending stent graft to treat a serious tear in the main artery from the heart (Type A aortic dissection). About 112 people with a recent tear will receive the stent graft through a small tube in a blood vessel, avoiding open-heart surgery. The goal is to see if the device is safe and works well to prevent death, stroke, or the need for more procedures.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AORTIC DISSECTION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Baylor Research Institute
RECRUITINGPlano, Texas, 75093, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Cleveland Clinic
RECRUITINGCleveland, Ohio, 44195, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Corewell Health System
RECRUITINGGrand Rapids, Michigan, 49503, United States
Contact Email: •••••@•••••
Contact
-
Duke University Medical Center
RECRUITINGDurham, North Carolina, 27710, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Emory University School of Medicine
RECRUITINGAtlanta, Georgia, 30322, United States
Contact
Contact Email: •••••@•••••
-
Hospital of the University of Pennsylvania
RECRUITINGPhiladelphia, Pennsylvania, 18104, United States
Contact
Contact Email: •••••@•••••
-
Indiana University
RECRUITINGIndianapolis, Indiana, 46202, United States
Contact Email: •••••@•••••
Contact
-
Massachusetts General Hospital
RECRUITINGBoston, Massachusetts, 02114, United States
Contact
Contact Email: •••••@•••••
-
Northwestern Medicine
RECRUITINGChicago, Illinois, 60611, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Ohio Health Research Institute
RECRUITINGColumbus, Ohio, 43214, United States
Contact
Contact Email: •••••@•••••
-
The Methodist Hospital Houston
RECRUITINGHouston, Texas, 77030, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
University of Alabama at Birmingham
RECRUITINGBirmingham, Alabama, 35294, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
University of Florida
RECRUITINGGainesville, Florida, 32608, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
University of Michigan
RECRUITINGAnn Arbor, Michigan, 48109, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
University of Southern California
RECRUITINGLos Angeles, California, 90033, United States
Contact Email: •••••@•••••
Contact
-
Washington University School of Medicine - St. Louis
RECRUITINGSt Louis, Missouri, 63110, United States
Contact Email: •••••@•••••
Contact
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.